Skip to main content

Advertisement

Table 2 Clinical outcomes after rebleeding in patients with small bowel angioectasia

From: Frequency and risk factors for rebleeding events in patients with small bowel angioectasia

  Patients with rebleeding
Number 23
Bleeding pattern (overt/occult) 12/11
Blood transfusion, number (%) 11 (47.8)
Minimum hemoglobin value after rebleeding, g/dl 9.1 ± 2.4
Endoscopic treatment, number (%) 8 (34.8)
Controlled by the end of the follow-up period*, number (%) 18 (78.3)
Iron replacement therapy after rebleeding, number (%) 23 (100)
Hemoglobin value at the end of the follow-up period, g/dl 11.4 ± 2.1
  1. *We defined OGIB as controlled if there was no further overt bleeding within 6 months and the hemoglobin level did not drop below 10 g/dl by the time of the final examination.